Stockscreener 앱 받기
62.25
5.81%
-3.84
시간 외 거래:
61.99
-0.26
-0.42%
전일 마감가:
$66.09
열려 있는:
$65.91
하루 거래량:
4.31M
Relative Volume:
0.90
시가총액:
$23.96B
수익:
$4.66B
순이익/손실:
$836.30M
주가수익비율:
29.74
EPS:
2.093
순현금흐름:
$1.08B
1주 성능:
-7.02%
1개월 성능:
-15.23%
6개월 성능:
-7.23%
1년 성능:
-10.39%
1일 변동 폭
$61.99
$65.91
1주일 범위
$61.99
$68.21
52주 변동 폭
$54.11
$89.98
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
62.25 | 23.96B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Precision Trading with Dexcom Inc. (DXCM) Risk Zones - Stock Traders Daily
DAVENPORT & Co LLC Reduces Stake in DexCom, Inc. - National Today
DXCM (DexCom) Earnings Power Value (EPV) : $11.42 (As of Dec25) - GuruFocus
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance UK
DEXCOM YoY EBITDA Growth: 52.52% | Significantly Undervalued - GuruFocus
Vanguard (DXCM) amendment shows 0 shares after internal realignment - Stock Titan
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DXCM (DexCom) Payments of Debt : $0 Mil (TTM As of Dec. 2025) - GuruFocus
DEXCOM EBIT per Share: $2.73 | Significantly Undervalued - GuruFocus
2026-03-26 | DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:DXCM | Press Release - Stockhouse
Dexcom Inc. stock surges on Evercore ISI upgrade to Outperform amid CGM market expansion - ad-hoc-news.de
Here's why you should hold DexCom stock in your portfolio for now - MSN
DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity - ChartMill
Nordea Investment Management AB Acquires 137,986 Shares of DexCom, Inc. $DXCM - MarketBeat
Assenagon Asset Management S.A. Increases Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Edges Up on Institutional Buying as CGM Leader Trails $260M Volume Ranks 465th - Bitget
Dexcom Inc. stock rises on Evercore ISI upgrade to Outperform with $90 target amid CGM market moment - ad-hoc-news.de
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom Inc. stock faces spotlight amid continuous glucose monitoring sector evolution and governance - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Investors to Connect - ACCESS Newswire
DexCom (NASDAQ:DXCM) Upgraded to "Outperform" at Evercore - MarketBeat
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
E. Ohman J or Asset Management AB Has $7.67 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
DexCom, Inc. $DXCM Shares Acquired by Gradient Investments LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages DexCom, Inc. (DXCM) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
DXCM Stock Price, Quote & Chart | DEXCOM INC (NASDAQ:DXCM) - chartmill.com
Devon Energy Corp stock eyes dividend surge amid Coterra merger push and rising oil prices - ad-hoc-news.de
Union Bancaire Privee UBP SA Increases Stake in DexCom - National Today
Union Bancaire Privee UBP SA Has $1.41 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DexCom, Inc. (DXCM) And Encourages Stockholders to Reach Out - ACCESS Newswire
Dexcom stock falls despite Q4 earnings beat, G7 rollout drives growth - MSN
Insider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of Stock - MarketBeat
Dexcom (DXCM) legal chief sells 1,700 shares in 10b5-1 trade - Stock Titan
Mizuho Markets Cayman LP Acquires 53,093 Shares of DexCom, Inc. $DXCM - MarketBeat
CIBC Private Wealth Group LLC Acquires 2,294,709 Shares of DexCom, Inc. $DXCM - MarketBeat
Block Trades: Will DexCom Inc outperform the market in YEAR2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Stockholders to Connect - ACCESS Newswire
DexCom, Inc. $DXCM Shares Purchased by Mizuho Markets Cayman LP - MarketBeat
Bank of Nova Scotia Trims Stake in DexCom - National Today
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia - MarketBeat
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know - Yahoo Finance
[144] DEXCOM INC SEC Filing - Stock Titan
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - Barchart
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? - Yahoo Finance
Iron Triangle Partners LP Purchases New Shares in DexCom, Inc. $DXCM - MarketBeat
Holocene Advisors Invests $163.96M in DexCom - National Today
Holocene Advisors LP Makes New $163.96 Million Investment in DexCom, Inc. $DXCM - MarketBeat
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
자본화:
|
볼륨(24시간):